LambdaVision raised $7 million to advance its protein-based artificial retina, a space-manufactured investigational device for the treatment of retinitis pigmentosa, a rare retinal degenerative disease.
LambdaVision raised $7 million to advance its protein-based artificial retina, a space-manufactured investigational device for the treatment of retinitis pigmentosa, a rare retinal degenerative disease.